Monday, 27 December 2010

Triamtereen-Hydrochloorthiazide A




Triamtereen-Hydrochloorthiazide A may be available in the countries listed below.


Ingredient matches for Triamtereen-Hydrochloorthiazide A



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Triamtereen-Hydrochloorthiazide A in the following countries:


  • Netherlands

Triamterene

Triamterene is reported as an ingredient of Triamtereen-Hydrochloorthiazide A in the following countries:


  • Netherlands

International Drug Name Search

Sunday, 26 December 2010

Omnipaque 300


See also: Generic Omnipaque 140, Generic Omnipaque 180, Generic Omnipaque 240, Generic Omnipaque 350


Omnipaque 300 is a brand name of iohexol, approved by the FDA in the following formulation(s):


OMNIPAQUE 300 (iohexol - solution; injection, oral, rectal)



  • Manufacturer: GE HEALTHCARE

    Approval date: December 26, 1985

    Strength(s): 64.7% [RLD]


  • Manufacturer: GE HEALTHCARE

    Approval date: October 24, 1995

    Strength(s): 64.7%

Has a generic version of Omnipaque 300 been approved?


No. There is currently no therapeutically equivalent version of Omnipaque 300 available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Omnipaque 300. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents

There are no current U.S. patents associated with Omnipaque 300.

See also...

    Saturday, 25 December 2010

    Ornisteril




    Ornisteril may be available in the countries listed below.


    In some countries, this medicine may only be approved for veterinary use.

    Ingredient matches for Ornisteril



    Progesterone

    Progesterone is reported as an ingredient of Ornisteril in the following countries:


    • France

    International Drug Name Search

    Naponal




    Naponal may be available in the countries listed below.


    Ingredient matches for Naponal



    Naproxen

    Naproxen sodium salt (a derivative of Naproxen) is reported as an ingredient of Naponal in the following countries:


    • Turkey

    International Drug Name Search

    Monday, 20 December 2010

    Pravastatin AbZ




    Pravastatin AbZ may be available in the countries listed below.


    Ingredient matches for Pravastatin AbZ



    Pravastatin

    Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Pravastatin AbZ in the following countries:


    • Germany

    International Drug Name Search

    Monday, 13 December 2010

    Citagen




    Citagen may be available in the countries listed below.


    Ingredient matches for Citagen



    Citalopram

    Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Citagen in the following countries:


    • Hungary

    International Drug Name Search

    Sunday, 12 December 2010

    Tenaten




    Tenaten may be available in the countries listed below.


    Ingredient matches for Tenaten



    Enalapril

    Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Tenaten in the following countries:


    • Indonesia

    International Drug Name Search

    Saturday, 11 December 2010

    GenRX Meloxicam




    GenRX Meloxicam may be available in the countries listed below.


    Ingredient matches for GenRX Meloxicam



    Meloxicam

    Meloxicam is reported as an ingredient of GenRX Meloxicam in the following countries:


    • Australia

    International Drug Name Search

    Thursday, 9 December 2010

    Entact




    Entact may be available in the countries listed below.


    Ingredient matches for Entact



    Escitalopram

    Escitalopram is reported as an ingredient of Entact in the following countries:


    • Portugal

    Escitalopram oxalate (a derivative of Escitalopram) is reported as an ingredient of Entact in the following countries:


    • Greece

    • Italy

    • Spain

    International Drug Name Search

    Gentalyn




    Gentalyn may be available in the countries listed below.


    Ingredient matches for Gentalyn



    Gentamicin

    Gentamicin is reported as an ingredient of Gentalyn in the following countries:


    • Peru

    Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentalyn in the following countries:


    • Chile

    • Italy

    • Venezuela

    International Drug Name Search

    Monday, 6 December 2010

    Diluran




    Diluran may be available in the countries listed below.


    Ingredient matches for Diluran



    Acetazolamide

    Acetazolamide is reported as an ingredient of Diluran in the following countries:


    • Czech Republic

    • Slovakia

    International Drug Name Search

    Tuesday, 23 November 2010

    Epirubicine Teva




    Epirubicine Teva may be available in the countries listed below.


    Ingredient matches for Epirubicine Teva



    Epirubicin

    Epirubicin hydrochloride (a derivative of Epirubicin) is reported as an ingredient of Epirubicine Teva in the following countries:


    • France

    International Drug Name Search

    Saturday, 20 November 2010

    Brompheniramine/Hydrocodone/Phenylephrine Suspension


    Generic Name: Brompheniramine/Hydrocodone/Phenylephrine (BROME-fen-IR-a-meen/hye-droe-KOE-done/FEN-il-EF-rin)
    Brand Name: VasoTuss HC


    Brompheniramine/Hydrocodone/Phenylephrine Suspension is used for:

    Relieving symptoms of sinus congestion, runny nose, sneezing, and cough due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.


    Brompheniramine/Hydrocodone/Phenylephrine Suspension is a decongestant, antihistamine, and cough suppressant combination. The decongestant works by constricting blood vessels and reducing swelling in the nasal passages. The antihistamine works by blocking the action of histamine, which helps reduce symptoms, such as watery eyes and sneezing. The cough suppressant works in the brain to help decrease the cough reflex, which reduces a dry cough.


    Do NOT use Brompheniramine/Hydrocodone/Phenylephrine Suspension if:


    • you are allergic to any ingredient in Brompheniramine/Hydrocodone/Phenylephrine Suspension or any other codeine- or morphine-related medicine (eg, codeine)

    • you have severe high blood pressure, severe heart blood vessel disease, rapid heartbeat, or severe heart problems

    • you are unable to urinate or are having an asthma attack

    • you are taking sodium oxybate (GHB) or if you have taken furazolidone or a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days

    Contact your doctor or health care provider right away if any of these apply to you.



    Before using Brompheniramine/Hydrocodone/Phenylephrine Suspension:


    Some medical conditions may interact with Brompheniramine/Hydrocodone/Phenylephrine Suspension. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


    • if you are pregnant, planning to become pregnant, or are breast-feeding

    • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

    • if you have allergies to medicines, foods, or other substances

    • if you have a fast, slow, or irregular heartbeat; heart blood vessel problems; or other heart problems

    • if you have a history of adrenal gland problems (eg, adrenal gland tumor); high blood pressure; diabetes; stroke; glaucoma; a blockage of your bladder, stomach, or intestines; ulcers; trouble urinating; an enlarged prostate or other prostate problems; or an overactive thyroid

    • if you have a history of asthma, chronic cough, lung problems (eg, chronic bronchitis, emphysema), or chronic obstructive pulmonary disease (COPD), or if your cough occurs with large amounts of mucus

    • if you have or recently have had any head or brain injury, brain tumor, increased pressure in the brain, infection of the brain or nervous system, epilepsy, or seizures

    • if you have a history of stomach problems (eg, ulcers), bowel problems (eg, chronic inflammation or ulceration of the bowel), gallbladder problems (eg, gallstones), or phenylketonuria, or if you have had recent abdominal surgery

    • if you have a history of alcohol or substance abuse or suicidal thoughts or behavior

    Some MEDICINES MAY INTERACT with Brompheniramine/Hydrocodone/Phenylephrine Suspension. Tell your health care provider if you are taking any other medicines, especially any of the following:


    • Beta-blockers (eg, propranolol), catechol-O-methyltransferase (COMT) inhibitors (eg, tolcapone), furazolidone, indomethacin, MAOIs (eg, phenelzine), or tricyclic antidepressants (eg, amitriptyline) because they may increase the risk of Brompheniramine/Hydrocodone/Phenylephrine Suspension's side effects

    • Cimetidine, digoxin, droxidopa, or sodium oxybate ( GHB) because the risk of severe drowsiness, breathing problems, seizures, irregular heartbeat, or heart attack may be increased

    • Naltrexone because it may decrease Brompheniramine/Hydrocodone/Phenylephrine Suspension's effectiveness

    • Bromocriptine or hydantoins (eg, phenytoin) because the risk of their side effects may be increased by Brompheniramine/Hydrocodone/Phenylephrine Suspension

    • Guanadrel, guanethidine, mecamylamine, methyldopa, or reserpine because their effectiveness may be decreased by Brompheniramine/Hydrocodone/Phenylephrine Suspension

    This may not be a complete list of all interactions that may occur. Ask your health care provider if Brompheniramine/Hydrocodone/Phenylephrine Suspension may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


    How to use Brompheniramine/Hydrocodone/Phenylephrine Suspension:


    Use Brompheniramine/Hydrocodone/Phenylephrine Suspension as directed by your doctor. Check the label on the medicine for exact dosing instructions.


    • Take Brompheniramine/Hydrocodone/Phenylephrine Suspension by mouth with or without food.

    • Shake well before each use.

    • Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.

    • If you miss a dose of Brompheniramine/Hydrocodone/Phenylephrine Suspension, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

    Ask your health care provider any questions you may have about how to use Brompheniramine/Hydrocodone/Phenylephrine Suspension.



    Important safety information:


    • Brompheniramine/Hydrocodone/Phenylephrine Suspension may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Brompheniramine/Hydrocodone/Phenylephrine Suspension with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

    • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Brompheniramine/Hydrocodone/Phenylephrine Suspension without first checking with your doctor; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

    • Do not take diet or appetite control medicines while you are taking Brompheniramine/Hydrocodone/Phenylephrine Suspension without checking with your doctor.

    • Brompheniramine/Hydrocodone/Phenylephrine Suspension has brompheniramine and phenylephrine in it. Before you start any new medicine, check the label to see if it has brompheniramine and phenylephrine in it too. If it does or if you are not sure, check with your doctor or pharmacist.

    • Some of these products contain phenylalanine. If you must have a diet that is low in phenylalanine, ask your pharmacist if it is in your product.

    • Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.

    • If your symptoms do not get better within 5 to 7 days or if they get worse, check with your doctor.

    • Brompheniramine/Hydrocodone/Phenylephrine Suspension may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Brompheniramine/Hydrocodone/Phenylephrine Suspension. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.

    • Brompheniramine/Hydrocodone/Phenylephrine Suspension may interfere with skin allergy tests. If you are scheduled for a skin test, talk to your doctor. You may need to stop taking Brompheniramine/Hydrocodone/Phenylephrine Suspension for a few days before the tests.

    • Tell your doctor or dentist that you take Brompheniramine/Hydrocodone/Phenylephrine Suspension before you receive any medical or dental care, emergency care, or surgery.

    • Use Brompheniramine/Hydrocodone/Phenylephrine Suspension with caution in the ELDERLY; they may be more sensitive to its effects.

    • Caution is advised when using Brompheniramine/Hydrocodone/Phenylephrine Suspension in CHILDREN; they may be more sensitive to its effects.

    • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of taking Brompheniramine/Hydrocodone/Phenylephrine Suspension while you are pregnant. It is not known if Brompheniramine/Hydrocodone/Phenylephrine Suspension is found in breast milk. Do not breast-feed while taking Brompheniramine/Hydrocodone/Phenylephrine Suspension.

    When used for long periods of time or at high doses, Brompheniramine/Hydrocodone/Phenylephrine Suspension may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Brompheniramine/Hydrocodone/Phenylephrine Suspension stops working well. Do not take more than prescribed.


    When used for long periods of time or at high doses, some people develop a need to continue taking Brompheniramine/Hydrocodone/Phenylephrine Suspension. This is known as DEPENDENCE or addiction.


    If you suddenly stop taking Brompheniramine/Hydrocodone/Phenylephrine Suspension, you may experience WITHDRAWAL symptoms including anxiety; diarrhea; fever, runny nose, or sneezing; goose bumps and abnormal skin sensations; nausea; vomiting; pain; rigid muscles; rapid heartbeat; seeing, hearing, or feeling things that are not there; shivering or tremors; sweating; and trouble sleeping.



    Possible side effects of Brompheniramine/Hydrocodone/Phenylephrine Suspension:


    All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



    Constipation; diarrhea; dizziness; drowsiness; excitability; headache; loss of appetite; nausea; nervousness or anxiety; upset stomach; vomiting; weakness.



    Seek medical attention right away if any of these SEVERE side effects occur:

    Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; severe or persistent trouble sleeping; tremor; vision changes.



    This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


    See also: Brompheniramine/Hydrocodone/Phenylephrine side effects (in more detail)


    If OVERDOSE is suspected:


    Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.


    Proper storage of Brompheniramine/Hydrocodone/Phenylephrine Suspension:

    Store Brompheniramine/Hydrocodone/Phenylephrine Suspension at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Brompheniramine/Hydrocodone/Phenylephrine Suspension out of the reach of children and away from pets.


    General information:


    • If you have any questions about Brompheniramine/Hydrocodone/Phenylephrine Suspension, please talk with your doctor, pharmacist, or other health care provider.

    • Brompheniramine/Hydrocodone/Phenylephrine Suspension is to be used only by the patient for whom it is prescribed. Do not share it with other people.

    • If your symptoms do not improve or if they become worse, check with your doctor.

    This information is a summary only. It does not contain all information about Brompheniramine/Hydrocodone/Phenylephrine Suspension. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



    Issue Date: February 1, 2012

    Database Edition 12.1.1.002

    Copyright © 2012 Wolters Kluwer Health, Inc.

    More Brompheniramine/Hydrocodone/Phenylephrine resources


    • Brompheniramine/Hydrocodone/Phenylephrine Side Effects (in more detail)
    • Brompheniramine/Hydrocodone/Phenylephrine Use in Pregnancy & Breastfeeding
    • Brompheniramine/Hydrocodone/Phenylephrine Drug Interactions
    • Brompheniramine/Hydrocodone/Phenylephrine Support Group
    • 0 Reviews for Brompheniramine/Hydrocodone/Phenylephrine - Add your own review/rating


    Compare Brompheniramine/Hydrocodone/Phenylephrine with other medications


    • Cough and Nasal Congestion

    Gentamytrex




    Gentamytrex may be available in the countries listed below.


    Ingredient matches for Gentamytrex



    Gentamicin

    Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentamytrex in the following countries:


    • Bahrain

    • Germany

    • Luxembourg

    • Poland

    • Singapore

    • Taiwan

    International Drug Name Search

    Wednesday, 17 November 2010

    Metoprolol-corax




    Metoprolol-corax may be available in the countries listed below.


    Ingredient matches for Metoprolol-corax



    Metoprolol

    Metoprolol tartrate (a derivative of Metoprolol) is reported as an ingredient of Metoprolol-corax in the following countries:


    • Germany

    International Drug Name Search

    Tuesday, 16 November 2010

    Valium




    In the US, Valium (diazepam systemic) is a member of the following drug classes: benzodiazepine anticonvulsants, benzodiazepines and is used to treat Alcohol Withdrawal, Anxiety, Endoscopy or Radiology Premedication, ICU Agitation, Light Anesthesia, Light Sedation, Meniere's Disease, Muscle Spasm, Night Terrors, Seizure Prevention, Seizures, Status Epilepticus, Temporomandibular Joint Disorder and Tetanus.

    US matches:

    • Valium

    • Valium Injection

    Ingredient matches for Valium



    Diazepam

    Diazepam is reported as an ingredient of Valium in the following countries:


    • Argentina

    • Australia

    • Belgium

    • France

    • Germany

    • Iceland

    • India

    • Indonesia

    • Ireland

    • Italy

    • Luxembourg

    • Malta

    • Mexico

    • Norway

    • Oman

    • Peru

    • Spain

    • Sri Lanka

    • Switzerland

    • Tunisia

    • United States

    International Drug Name Search

    Saturday, 13 November 2010

    Piros




    Piros may be available in the countries listed below.


    Ingredient matches for Piros



    Paracetamol

    Paracetamol is reported as an ingredient of Piros in the following countries:


    • Italy

    International Drug Name Search

    Tuesday, 9 November 2010

    Clavamel




    Clavamel may be available in the countries listed below.


    Ingredient matches for Clavamel



    Amoxicillin

    Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Clavamel in the following countries:


    • Ireland

    Clavulanate

    Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Clavamel in the following countries:


    • Ireland

    International Drug Name Search

    Sunday, 7 November 2010

    Balanced Salt Solution





    Dosage Form: irrigating solution
    Balanced Salt Solution

    Sterile Irrigating Solution

    Balanced Salt Solution Description


    Balanced Salt Solution Sterile Irrigating Solution is a sterile Balanced Salt Solution, each mL containing sodium chloride (NaCl) 0.64%, potassium chloride (KCl) 0.075%, calcium chloride dihydrate (CaCl2·2H2O) 0.048%, magnesium chloride hexahydrate (MgCl2·6H2O) 0.03%, sodium acetate trihydrate (C2H3NaO2·3H2O) 0.39%, sodium citrate dihydrate (C6H5Na3O7·2H2O) 0.17%, sodium hydroxide and/or hydrochloric acid (to adjust pH), and water for injection.


    The pH is approximately 7.0.


    The osmolality is approximately 300 mOsm/Kg.



    Balanced Salt Solution - Clinical Pharmacology


    Balanced Salt Solution Sterile Irrigating Solution is an isotonic solution for use in irrigating tissues of the eyes.



    Indications and Usage for Balanced Salt Solution


    For use as an extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes.



    Warnings


    • NOT FOR INJECTION OR INTRAVENOUS INFUSION.

    • Do not use unless product is clear, seal is intact and container is undamaged.

    • Do not use if product is discolored or contains a precipitate.

    • SINGLE patient use only. The contents of this bottle should not be used in more than one patient.

    • The use of additives with this solution may cause corneal decompensation.

    • This solution contains no preservative, unused contents should be discarded.


    Precautions


    Open under aseptic conditions only.


    Studies suggest that intraocular irrigating solutions which are iso-osmotic with normal aqueous fluids should be used with caution in diabetic patients undergoing vitrectomy since intraoperative lens changes have been observed.


    There have been reports of corneal clouding or edema following ocular surgery in which Balanced Salt Solution Sterile Irrigating Solution was used as an irrigating solution.



    Adverse Reactions


    Irrigation or any other trauma may result in corneal swelling or bullous keratopathy.


    Post-operative inflammatory reactions as well as incidents of corneal edema and corneal decompensation have been reported.



    Balanced Salt Solution Dosage and Administration


    The irrigating solution should be used according to standard format for each surgical procedure. Note: Use an administration set with an air-inlet in the plastic spike since the bottle does not contain a separate airway tube. Follow directions of the particular administration set to be used. Remove the aluminum tab. Clean and disinfect the rubber stopper by using a sterile alcohol wipe. Insert the spike aseptically into the bottle through the target area of the rubber stopper. Allow the fluid to flow and remove air from the tubing before irrigation begins.



    How is Balanced Salt Solution Supplied


    Balanced Salt Solution Sterile Irrigating Solution is supplied in a glass bottle using a gray butyl stopper and aluminum closure with a tear tab.









    NDCREFSize
    Balanced Salt Solution Sterile Irrigating Solution
    0264-2514-10S2514-10500 mL

    STORAGE


    Store at 20–25°C (68–77°F). Excursions permitted to 15–30°C (59–86°F). [See USP Controlled Room Temperature.] Protect from freezing.



     


    Rx Only


    Issued: November 2009


    B. Braun Medical Inc.

    Irvine, CA 92614-5895 USA

    Made in USA


    Y36-002-712



    PRINCIPAL DISPLAY PANEL - 500 mL Label


    Balanced Salt Solution


    Sterile Irrigating Solution


    NDC 0264-2514-10

    REF S2514-10


    500 mL


    NOT FOR I.V. USE

    SINGLE USE ONLY


    B. Braun Medical Inc.

    Irvine, CA 92614-5895 USA

    Made in USA










    BALANCED SALT 
    sodium chloride, potassium chloride, calcium chloride, magnesium chloride, sodium acetate, and sodium citrate  solution










    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)0264-2514
    Route of AdministrationIRRIGATIONDEA Schedule    























    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Sodium Chloride (SODIUM CATION)Sodium Chloride6.4 mg  in 1 mL
    Potassium Chloride (POTASSIUM CATION)Potassium Chloride0.75 mg  in 1 mL
    Calcium Chloride (CALCIUM CATION)Calcium Chloride0.48 mg  in 1 mL
    Magnesium Chloride (MAGNESIUM CATION)Magnesium Chloride0.3 mg  in 1 mL
    Sodium Acetate (SODIUM CATION)Sodium Acetate3.9 mg  in 1 mL
    Sodium Citrate (SODIUM CATION)Sodium Citrate1.7 mg  in 1 mL










    Inactive Ingredients
    Ingredient NameStrength
    Sodium Hydroxide 
    Hydrochloric Acid 
    Water 


















    Product Characteristics
    Color    Score    
    ShapeSize
    FlavorImprint Code
    Contains      














    Packaging
    #NDCPackage DescriptionMultilevel Packaging
    10264-2514-1012 BOTTLE In 1 CASEcontains a BOTTLE, GLASS
    1500 mL In 1 BOTTLE, GLASSThis package is contained within the CASE (0264-2514-10)










    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA09138702/03/2010


    Labeler - B. Braun Medical Inc. (002397347)









    Establishment
    NameAddressID/FEIOperations
    B Braun Medical Inc037425308MANUFACTURE
    Revised: 01/2011B. Braun Medical Inc.

    More Balanced Salt Solution resources


    • Balanced Salt Solution Side Effects (in more detail)
    • Balanced Salt Solution Support Group
    • 0 Reviews · Be the first to review/rate this drug

    Bromhist-DM Drops


    Generic Name: brompheniramine, dextromethorphan, and pseudoephedrine (brom fen EER a meen, dex troe me THOR fan, soo doe e FED rin)

    Brand Names: Allanhist PDX Drops, Anaplex DM, Anaplex DMX, Andehist DM NR Syrup, Brom Tann, Bromaline DM, Bromdex D, Bromfed DM, Bromhist PDX, Bromhist-DM Drops, Bromophed-DX, Bromph DM, Bromplex DM, BroveX PSE DM, Dallergy DM, EndaCof-DM, Histacol BD Drops, Myphetane DX Cough, Neo DM, PBM Allergy, Pediahist DM Drops, ProHist DM, Q-Tapp DM, Resperal-DM Drops, Robitussin Allergy & Cough, Sildec DM


    What is Bromhist-DM Drops (brompheniramine, dextromethorphan, and pseudoephedrine)?

    Brompheniramine is an antihistamine that reduces the effects of the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.


    Dextromethorphan is a cough suppressant. It affects the signals in the brain that trigger cough reflex.


    Pseudoephedrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).


    The combination of brompheniramine, dextromethorphan, and pseudoephedrine is used to treat runny or stuffy nose, sneezing, itching, watery eyes, cough, and sinus congestion caused by allergies, the common cold, or the flu.


    This medicine will not treat a cough that is caused by smoking, asthma, or emphysema.

    Brompheniramine, dextromethorphan, and pseudoephedrine may also be used for purposes not listed in this medication guide.


    What is the most important information I should know about Bromhist-DM Drops (brompheniramine, dextromethorphan, and pseudoephedrine)?


    Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. You should not use this medication if you have severe constipation, a blockage in your stomach or intestines, or if you are unable to urinate. Do not use cough or cold medicine if you have untreated or uncontrolled diseases such as glaucoma, asthma or COPD, high blood pressure, heart disease, coronary artery disease, or overactive thyroid. Do not use cough or cold medicine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

    What should I discuss with my healthcare provider before taking Bromhist-DM Drops (brompheniramine, dextromethorphan, and pseudoephedrine)?


    Do not use cough or cold medicine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects. You should not use this medication if you have severe constipation, a blockage in your stomach or intestines, or if you are unable to urinate. Do not use cough or cold medicine if you have untreated or uncontrolled diseases such as glaucoma, asthma or COPD, high blood pressure, heart disease, coronary artery disease, or overactive thyroid.

    Ask a doctor or pharmacist if it is safe for you to take this medication if you have:



    • a blockage in your digestive tract (stomach or intestines), a colostomy or ileostomy;




    • diabetes;




    • liver or kidney disease;




    • epilepsy or other seizure disorder;




    • cough with mucus, or cough caused by emphysema or chronic bronchitis;




    • enlarged prostate or urination problems;




    • low blood pressure;




    • pheochromocytoma (an adrenal gland tumor); or




    • if you take potassium (Cytra, Epiklor, K-Lyte, K-Phos, Kaon, Klor-Con, Polycitra, Urocit-K).




    FDA pregnancy category C. It is not known whether this medication will harm an unborn baby. Do not use cough or cold medicine without medical advice if you are pregnant. This medicine may pass into breast milk and may harm a nursing baby. Antihistamines and decongestants may also slow breast milk production. Do not use cough or cold medicine without medical advice if you are breast-feeding a baby.

    How should I take Bromhist-DM Drops (brompheniramine, dextromethorphan, and pseudoephedrine)?


    Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Cough or cold medicine is usually taken only for a short time until your symptoms clear up.


    Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children.

    Do not take for longer than 7 days in a row. Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache or skin rash.


    Measure liquid medicine with a special dose-measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


    If you need surgery or medical tests, tell the surgeon or doctor ahead of time if you have taken a cough or cold medicine within the past few days. Store at room temperature away from moisture and heat. Do not freeze.

    What happens if I miss a dose?


    Since cough or cold medicine is taken when needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


    What happens if I overdose?


    Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

    Overdose symptoms may include severe forms of some of the side effects listed in this medication guide.


    What should I avoid while taking Bromhist-DM Drops (brompheniramine, dextromethorphan, and pseudoephedrine)?


    This medicine may cause blurred vision and may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert and able to see clearly. Drinking alcohol can increase certain side effects of this medication. Ask a doctor or pharmacist before using any other cold, allergy, cough, or sleep medicine. Antihistamines, cough suppressants, and decongestants are contained in many combination medicines. Taking certain products together can cause you to get too much of a certain drug. Check the label to see if a medicine contains an antihistamine, cough suppressant, or decongestant.

    Avoid taking this medication if you also take diet pills, caffeine pills, or other stimulants (such as ADHD medications). Taking a stimulant together with a decongestant can increase your risk of unpleasant side effects.


    Avoid becoming overheated or dehydrated during exercise and in hot weather. This medication can decrease sweating and you may be more prone to heat stroke.

    Bromhist-DM Drops (brompheniramine, dextromethorphan, and pseudoephedrine) side effects


    Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using this medicine and call your doctor at once if you have a serious side effect such as:

    • fast, slow, or uneven heart rate;




    • severe headache, mood changes, hallucinations;




    • severe dizziness or anxiety, feeling like you might pass out;




    • tremor, seizure (convulsions);




    • easy bruising or bleeding, unusual weakness;




    • fever;




    • urinating less than usual or not at all;




    • feeling short of breath; or




    • dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, uneven heartbeats, seizure).



    Less serious side effects may include:



    • mild headache;




    • mild dizziness, drowsiness;




    • dry mouth, nose, or throat;




    • nausea, diarrhea, constipation, upset stomach;




    • feeling nervous, restless, or irritable;




    • blurred vision; or




    • sleep problems (insomnia).



    This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


    What other drugs will affect Bromhist-DM Drops (brompheniramine, dextromethorphan, and pseudoephedrine)?


    Ask a doctor or pharmacist before using this medicine if you regularly use other medicines that make you sleepy (such as narcotic pain medication, sedatives, sleeping pills, muscle relaxers, and medicine for seizures, depression or anxiety). They can add to sleepiness caused by brompheniramine or dextromethorphan.


    Ask a doctor or pharmacist if it is safe for you to take this medication if you are also using any of the following drugs:



    • atropine (Atreza, Sal-Tropine);




    • benztropine (Cogentin);




    • topiramate (Topamax);




    • zonisamide (Zonegran);




    • an antidepressant such as citalopram (Celexa), duloxetine (Cymbalta), escitalopram (Lexapro), fluoxetine (Prozac, Sarafem, Symbyax), paroxetine (Paxil, Pexeva), sertraline (Zoloft), venlafaxine (Effexor), and others;




    • anti-nausea medications such as belladonna (Donnatal), dimenhydrinate (Dramamine), droperidol (Inapsine), methscopolamine (Pamine), or scopolamine (Transderm Scop);




    • bladder or urinary medications such as darifenacin (Enablex), flavoxate (Urispas), oxybutynin (Ditropan, Oxytrol), solifenacin (Vesicare), tolterodine (Detrol), or Urogesic Blue;




    • bronchodilators such as ipratropium (Atrovent) or tiotropium (Spiriva);




    • irritable bowel medications such as dicyclomine (Bentyl), hyoscyamine (Hyomax), or propantheline (Pro Banthine); or




    • ulcer medicine such as glycopyrrolate (Robinul) or mepenzolate (Cantil).



    This list is not complete and other drugs may interact with brompheniramine, dextromethorphan, and pseudoephedrine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



    More Bromhist-DM Drops resources


    • Bromhist-DM Drops Use in Pregnancy & Breastfeeding
    • Bromhist-DM Drops Drug Interactions
    • Bromhist-DM Drops Support Group
    • 0 Reviews for Bromhist-DM - Add your own review/rating


    • Anaplex DMX Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

    • Bromdex D Prescribing Information (FDA)

    • Bromfed DM Elixir MedFacts Consumer Leaflet (Wolters Kluwer)

    • Bromfed DM Prescribing Information (FDA)

    • Myphetane DX Prescribing Information (FDA)

    • Neo DM Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

    • Resperal-DM Drops MedFacts Consumer Leaflet (Wolters Kluwer)



    Compare Bromhist-DM Drops with other medications


    • Cough and Nasal Congestion


    Where can I get more information?


    • Your pharmacist can provide more information about brompheniramine, dextromethorphan, and pseudoephedrine.


    Voxamine




    Voxamine may be available in the countries listed below.


    Ingredient matches for Voxamine



    Difenidol

    Difenidol hydrochloride (a derivative of Difenidol) is reported as an ingredient of Voxamine in the following countries:


    • Mexico

    International Drug Name Search

    Saturday, 6 November 2010

    Pizo-A




    Pizo-A may be available in the countries listed below.


    Ingredient matches for Pizo-A



    Pizotifen

    Pizotifen is reported as an ingredient of Pizo-A in the following countries:


    • Bangladesh

    International Drug Name Search

    Tuesday, 26 October 2010

    Dibelet




    Dibelet may be available in the countries listed below.


    Ingredient matches for Dibelet



    Glibenclamide

    Glibenclamide is reported as an ingredient of Dibelet in the following countries:


    • Singapore

    International Drug Name Search

    Monday, 25 October 2010

    APC-Loperamide




    APC-Loperamide may be available in the countries listed below.


    Ingredient matches for APC-Loperamide



    Loperamide

    Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of APC-Loperamide in the following countries:


    • Canada

    International Drug Name Search

    olsalazine


    Generic Name: olsalazine (ole SAL a zeen)

    Brand Names: Dipentum


    What is olsalazine?

    Olsalazine affects substances in the body that cause inflammation, tissue damage, and diarrhea.


    Olsalazine is used to treat ulcerative colitis.


    Olsalazine may also be used for other purposes not listed in this medication guide.


    What is the most important information I should know about olsalazine?


    You should not use this medication if you are allergic to olsalazine or to salicylates such as aspirin, Novasal, Doan's Extra Strength, Salflex, Tricosal, and others.

    Before taking olsalazine, tell your doctor if you have asthma or other allergies, kidney disease, or liver disease.


    Call your doctor at once if your colitis symptoms get worse, or if you have chest pain, shortness of breath, fast or pounding heartbeats, nausea, stomach pain, loss of appetite, itching, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).

    What should I discuss with my healthcare provider before taking olsalazine?


    You should not use this medication if you are allergic to olsalazine or to salicylates such as aspirin, Novasal, Doan's Extra Strength, Salflex, Tricosal, and others.

    Before taking olsalazine, tell your doctor if you are allergic to any drugs, or if you have:



    • asthma or other allergies;




    • kidney disease; or




    • liver disease.



    If you have any of these conditions, you may need a dose adjustment or special tests to safely take olsalazine.


    FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Olsalazine can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

    How should I take olsalazine?


    Take this medication exactly as prescribed by your doctor. Do not take it in larger amounts or for longer than recommended. Follow the directions on your prescription label.


    Take olsalazine with a full glass of water. Store olsalazine at room temperature away from moisture and heat.

    See also: Olsalazine dosage (in more detail)

    What happens if I miss a dose?


    Take the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. Do not take extra medicine to make up the missed dose.


    What happens if I overdose?


    Seek emergency medical attention if you think you have used too much of this medicine.

    Overdose symptoms may include nausea, vomiting, and diarrhea.


    What should I avoid while taking olsalazine?


    Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are using olsalazine.


    Avoid getting a varicella (chickenpox) vaccine within 6 weeks after you stop taking olsalazine.


    Olsalazine side effects


    Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using olsalazine and call your doctor at once if you have any of these serious side effects:

    • worsening colitis (fever, stomach pain, cramping, or bloody diarrhea);




    • chest pain, shortness of breath, fast or pounding heartbeats; or




    • nausea, stomach pain, loss of appetite, itching, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).



    Less serious side effects may include:



    • mild stomach discomfort;




    • nausea, heartburn;




    • skin rash, itching;




    • headache;




    • muscle or joint pain; or




    • urinating more often than usual.



    This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


    Olsalazine Dosing Information


    Usual Adult Dose for Ulcerative Colitis -- Active:

    500 mg - 1 g orally per day, given in 2 equally divided dosages. Alternatively, doses of 500 mg up to 4 times a day have been used in severe cases.

    Usual Adult Dose for Ulcerative Colitis -- Maintenance:

    500 mg orally twice a day.

    Usual Adult Dose for Ankylosing Spondylitis:

    Study (n=4)
    500 mg 2 times daily for one week, increased by 500 mg weekly to a maximum of 1 g 3 times daily, for a total of 6 months.

    Usual Pediatric Dose for Ulcerative Colitis:

    Study (n=56)
    Greater than or equal to 2 years: 30 mg/kg/day (maximum, 2 g/day), starting at 25% of calculated daily dose, and increasing by one dose every third day, to four doses per day.


    What other drugs will affect olsalazine?


    The following drugs can interact with olsalazine. Tell your doctor if you are using any of these:



    • a blood thinner such as warfarin (Coumadin);




    • thioguanine; or




    • mercaptopurine (Purinethol).



    This list is not complete and there may be other drugs that can interact with olsalazine. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



    More olsalazine resources


    • Olsalazine Side Effects (in more detail)
    • Olsalazine Dosage
    • Olsalazine Use in Pregnancy & Breastfeeding
    • Olsalazine Drug Interactions
    • Olsalazine Support Group
    • 0 Reviews for Olsalazine - Add your own review/rating


    • olsalazine Advanced Consumer (Micromedex) - Includes Dosage Information

    • Olsalazine MedFacts Consumer Leaflet (Wolters Kluwer)

    • Dipentum Prescribing Information (FDA)

    • Dipentum Monograph (AHFS DI)



    Compare olsalazine with other medications


    • Ankylosing Spondylitis
    • Ulcerative Colitis
    • Ulcerative Colitis, Active
    • Ulcerative Colitis, Maintenance


    Where can I get more information?


    • Your pharmacist can provide more information about olsalazine.

    See also: olsalazine side effects (in more detail)


    Thursday, 21 October 2010

    Cisplamerck




    Cisplamerck may be available in the countries listed below.


    Ingredient matches for Cisplamerck



    Cisplatin

    Cisplatin is reported as an ingredient of Cisplamerck in the following countries:


    • Japan

    International Drug Name Search

    Sunday, 17 October 2010

    Diazossido




    Diazossido may be available in the countries listed below.


    Ingredient matches for Diazossido



    Diazoxide

    Diazossido (DCIT) is known as Diazoxide in the US.

    International Drug Name Search

    Glossary

    DCITDenominazione Comune Italiana

    Click for further information on drug naming conventions and International Nonproprietary Names.

    bisacodyl and polyethylene glycol (PEG) 3350 with electrolytes


    Generic Name: bisacodyl and polyethylene glycol (PEG) 3350 with electrolytes (bis a KOE dil and pol ee ETH il een GLYE kol)

    Brand Names: Half Lytely and Bisacodyl Lemon Lime, HalfLytely and Bisacodyl, HalfLytely and Bisacodyl with Flavor Packs


    What is bisacodyl and PEG-3350?

    Bisacodyl and PEG-3350 is a laxative that stimulates bowel movements. This medication also contains potassium, sodium, and other minerals to replace electrolytes that are passed from the body in the stool.


    Bisacodyl and PEG-3350 is used to clean the bowel before colonoscopy or other intestinal procedure.


    Bisacodyl and PEG-3350 may also be used for purposes not listed in this medication guide.


    What is the most important information I should know about bisacodyl and PEG-3350?


    On the day of your colonoscopy or bowel exam, do not eat solid food or drink anything other than clear liquids. Avoid drinking large amounts of water after taking this medication. You may be instructed not to drink or eat anything before your medical test or procedure. Follow your doctor's instructions about the type and amount of liquids you should drink for at least 24 hours before and after your test or procedure.

    Avoid taking antacids within 1 hour before you take the bisacodyl tablets.


    Do not use other laxatives while using bisacodyl and PEG-3350 unless your doctor has told you to.

    Talk to your doctor if you cannot drink all of the medication prescribed for you. Your test or procedure may need to be rescheduled if your bowel is not completely cleansed.


    What should I discuss with my health care provider before taking bisacodyl and PEG-3350?


    Do not use this medication if you are allergic to:

    • bisacodyl (Bisac-Evac, Carter's Little Pills, Dulcolax, Fleet, and others);




    • polyethylene glycol (GlycoLax, MiraLax); or




    • any other electrolyte solutions (such as Pedialyte or Gatorade).




    You should not use bisacodyl and PEG-3350 with electrolytes if you have a perforated bowel, a bowel obstruction or severe constipation, or colitis or toxic megacolon. If you have any these conditions, you could have dangerous or life-threatening side effects from bisacodyl and PEG-3350.

    People with eating disorders (such as anorexia or bulimia) should not use this medication without the advice of a doctor.


    To make sure you can safely use this medication, tell your doctor if you have any of these other conditions:



    • kidney disease;




    • nausea, vomiting, or trouble swallowing;




    • a history of bowel obstruction, diverticulitis, ulcerative colitis, or other chronic bowel disease; or




    • if you are taking a diuretic ("water pill").




    FDA pregnancy category C. It is not known whether this medication will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. It is not known whether bisacodyl and PEG-3350 passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not give this medicine to a child unless your doctor has told you to.

    How should I take bisacodyl and PEG-3350?


    Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.


    This medicine comes in a kit containing 2 bisacodyl delayed-release tablets and a bottle of PEG-3350 with electrolytes in powder form. You will take the bisacodyl tablets first and then wait to have a bowel movement. Once you have a bowel movement, you will start using the PEG-3350 solution over a period of about 90 minutes.


    Bisacodyl delayed-release tablets:


    Do not crush, chew, or break the bisacodyl delayed-release tablets. Swallow the tablets whole with a glass of water. Breaking the pill would cause too much of the drug to be released at one time.

    You should have a bowel movement within 1 to 6 hours after taking the bisacodyl tablets. After your first bowel movement, start using the PEG-3350 and electrolyte solution.


    Polyethylene glycol 3350 and electrolyte solution:


    The PEG-3350 and electrolyte powder must be mixed with water before you take it. Fill the container with water up to the 2-liter mark. Place the cap on the bottle and shake it until the powder is completely dissolved.


    A variety of flavor packs are provided with the PEG-3350 powder. Use only one pack to add flavor to the solution. You may also prepare the solution without a flavor pack. Do not add any extra flavorings such as sugar, honey, artificial sweetener, fruit juices, or other beverages.


    Shake the liquid well just before you measure each dose. The usual dose of PEG-3350 solution is 8 ounces every 10 minutes. Drink the solution in the exact portions at the exact time intervals prescribed by your doctor.

    Drink each portion as quickly as possible, rather than sipping it slowly. The first watery stool should appear within 1 hour after you start drinking the PEG-3350 and electrolyte solution.


    You may store the mixed solution in a refrigerator but you must use it within 48 hours after mixing. Throw away any PEG-3350 solution you have not used within 48 hours after it was mixed.

    PEG-3350 will produce watery diarrhea. Keep drinking the solution until you have consumed all 2 liters.


    On the day of your colonoscopy or bowel exam, do not eat solid food or drink anything other than clear liquids. You may be instructed not to drink or eat anything before your medical test or procedure. Follow your doctor's instructions about the type and amount of liquids you should drink for at least 24 hours before and after your test or procedure.

    What happens if I miss a dose?


    Talk to your doctor if you cannot drink all of the medication prescribed for you. Your test or procedure may need to be rescheduled if your bowel is not completely cleansed.


    What happens if I overdose?


    Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

    What should I avoid while taking bisacodyl and PEG-3350?


    Avoid drinking large amounts of water while you are using this medicine. Follow your doctor's instructions about the type and amount of liquids you should drink. Drinking too much liquid can be unsafe while you are using bisacodyl and PEG-3350.

    Avoid taking antacids within 1 hour before you take the bisacodyl tablets.


    Avoid taking other medications, vitamins, or mineral supplements within 1 hour before drinking the PEG-3350 electrolyte solution. Any medications you take just before a bowel cleansing will not be properly absorbed into your body.


    Do not use other laxatives while using bisacodyl and PEG-3350 unless your doctor has told you to.

    Bisacodyl and PEG-3350 side effects


    Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor if you have any of these serious side effects:

    • seizure (convulsions);




    • severe nausea, severe stomach pain or bloating;




    • coughing up blood or vomit that looks like coffee grounds;




    • rectal bleeding;




    • no bowel movement within 6 hours after use; or




    • gagging, choking, or vomiting.



    Some of these side effects may be prevented by drinking the medication more slowly, or not using it for a short time. Follow your doctor's instructions.


    Less serious side effects may include:



    • mild nausea or vomiting;




    • mild stomach cramps, or full feeling;




    • rectal pain or irritation;




    • passing gas; or




    • headache.



    This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


    Bisacodyl and polyethylene glycol (PEG) 3350 with electrolytes Dosing Information


    Usual Adult Dose for Bowel Preparation:

    Bisacodyl 20 mg (4 tablets) orally once. Following first bowel movement, or 6 hours after ingestion of bisacodyl tablets, begin PEG-ELS 240 mL every 10 minutes until 2 liters is totally consumed.


    What other drugs will affect bisacodyl and PEG-3350?


    Before taking this medication, tell your doctor if you are also taking a diuretic (water pill), or any heart or blood pressure medication.


    There may be other drugs that can interact with bisacodyl and PEG-3350.. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



    More bisacodyl and polyethylene glycol (PEG) 3350 with electrolytes resources


    • Bisacodyl and polyethylene glycol (PEG) 3350 with electrolytes Use in Pregnancy & Breastfeeding
    • Bisacodyl and polyethylene glycol (PEG) 3350 with electrolytes Drug Interactions
    • Bisacodyl and polyethylene glycol (PEG) 3350 with electrolytes Support Group
    • 2 Reviews for Bisacodyl and polyethylene glycol (PEG) 3350 with electrolytes - Add your own review/rating


    Compare bisacodyl and polyethylene glycol (PEG) 3350 with electrolytes with other medications


    • Bowel Preparation


    Where can I get more information?


    • Your pharmacist can provide more information about bisacodyl and PEG-3350.


    Sunday, 3 October 2010

    Himox-B




    Himox-B may be available in the countries listed below.


    Ingredient matches for Himox-B



    Amoxicillin

    Amoxicillin is reported as an ingredient of Himox-B in the following countries:


    • India

    Bromhexine

    Bromhexine is reported as an ingredient of Himox-B in the following countries:


    • India

    International Drug Name Search

    Modificial




    Modificial may be available in the countries listed below.


    Ingredient matches for Modificial



    Ondansetron

    Ondansetron is reported as an ingredient of Modificial in the following countries:


    • Colombia

    • Ecuador

    • Peru

    Ondansetron hydrochloride (a derivative of Ondansetron) is reported as an ingredient of Modificial in the following countries:


    • Brazil

    International Drug Name Search

    Sunday, 26 September 2010

    Conofite




    In some countries, this medicine may only be approved for veterinary use.

    Ingredient matches for Conofite



    Miconazole

    Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Conofite in the following countries:


    • Australia

    • United States

    International Drug Name Search

    Monday, 20 September 2010

    Zolpidem Edigen




    Zolpidem Edigen may be available in the countries listed below.


    Ingredient matches for Zolpidem Edigen



    Zolpidem

    Zolpidem tartrate (a derivative of Zolpidem) is reported as an ingredient of Zolpidem Edigen in the following countries:


    • Spain

    International Drug Name Search

    Sunday, 19 September 2010

    Starcitin ES




    Starcitin ES may be available in the countries listed below.


    Ingredient matches for Starcitin ES



    Escitalopram

    Escitalopram is reported as an ingredient of Starcitin ES in the following countries:


    • Croatia (Hrvatska)

    International Drug Name Search

    Friday, 10 September 2010

    Vexol




    In some countries, this medicine may only be approved for veterinary use.


    In the US, Vexol (rimexolone ophthalmic) is a member of the drug class ophthalmic steroids and is used to treat Postoperative Ocular Inflammation and Uveitis.

    US matches:

    • Vexol

    UK matches:

    • Vexol 1%
    • Vexol 1% Eye Drops, Suspension (SPC)

    Ingredient matches for Vexol



    Rimexolone

    Rimexolone is reported as an ingredient of Vexol in the following countries:


    • Austria

    • Brazil

    • Canada

    • Denmark

    • Finland

    • France

    • Germany

    • Greece

    • Ireland

    • Italy

    • Mexico

    • Netherlands

    • Norway

    • Portugal

    • Spain

    • Sweden

    • Switzerland

    • Turkey

    • United Kingdom

    • United States

    International Drug Name Search

    Glossary

    SPC Summary of Product Characteristics (UK)

    Click for further information on drug naming conventions and International Nonproprietary Names.

    Tuesday, 7 September 2010

    Topharmin




    Topharmin may be available in the countries listed below.


    Ingredient matches for Topharmin



    Amantadine

    Amantadine hydrochloride (a derivative of Amantadine) is reported as an ingredient of Topharmin in the following countries:


    • Japan

    International Drug Name Search

    Friday, 3 September 2010

    Ticlopidina Ciclum




    Ticlopidina Ciclum may be available in the countries listed below.


    Ingredient matches for Ticlopidina Ciclum



    Ticlopidine

    Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Ticlopidina Ciclum in the following countries:


    • Portugal

    International Drug Name Search

    Saturday, 21 August 2010

    Undestor Testocaps




    Undestor Testocaps may be available in the countries listed below.


    Ingredient matches for Undestor Testocaps



    Testosterone

    Testosterone undecanoate (a derivative of Testosterone) is reported as an ingredient of Undestor Testocaps in the following countries:


    • Sweden

    International Drug Name Search

    Thursday, 12 August 2010

    Visclair




    Visclair may be available in the countries listed below.


    Ingredient matches for Visclair



    Mecysteine

    Mecysteine hydrochloride (a derivative of Mecysteine) is reported as an ingredient of Visclair in the following countries:


    • Ireland

    • United Kingdom

    International Drug Name Search

    Wednesday, 11 August 2010

    Aknichthol




    Aknichthol may be available in the countries listed below.


    Ingredient matches for Aknichthol



    Ichthammol

    Ichthammol sodium salt, decolorized (a derivative of Ichthammol) is reported as an ingredient of Aknichthol in the following countries:


    • Germany

    International Drug Name Search

    Thursday, 5 August 2010

    Dainazol




    Dainazol may be available in the countries listed below.


    Ingredient matches for Dainazol



    Danazol

    Danazol is reported as an ingredient of Dainazol in the following countries:


    • Japan

    International Drug Name Search

    Monday, 2 August 2010

    Zyrtec




    In the US, Zyrtec (cetirizine systemic) is a member of the drug class antihistamines and is used to treat Hay Fever and Urticaria.

    US matches:

    • Zyrtec

    • Zyrtec Chewable Tablets

    • Zyrtec Syrup

    • Zyrtec-D 12 Hour

    • Zyrtec Hives

    • Zyrtec-D

    • Zyrtec Itchy Eye

    • Zyrtec Capsule

    • Zyrtec Tablets

    Ingredient matches for Zyrtec



    Cetirizine

    Cetirizine is reported as an ingredient of Zyrtec in the following countries:


    • Tunisia

    Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Zyrtec in the following countries:


    • Algeria

    • Argentina

    • Australia

    • Austria

    • Belgium

    • Benin

    • Brazil

    • Burkina Faso

    • Cameroon

    • Central African Republic

    • Chad

    • Chile

    • Colombia

    • Congo

    • Cote D'ivoire

    • Czech Republic

    • Denmark

    • Estonia

    • Finland

    • France

    • Gabon

    • Georgia

    • Germany

    • Guinea

    • Guyana

    • Hong Kong

    • Hungary

    • India

    • Japan

    • Latvia

    • Lithuania

    • Luxembourg

    • Madagascar

    • Malaysia

    • Mali

    • Malta

    • Mauritania

    • Mauritius

    • Mexico

    • Myanmar

    • Netherlands

    • New Zealand

    • Niger

    • Norway

    • Oman

    • Peru

    • Philippines

    • Poland

    • Portugal

    • Romania

    • Russian Federation

    • Senegal

    • Singapore

    • Slovenia

    • South Africa

    • Spain

    • Switzerland

    • Taiwan

    • Thailand

    • Togo

    • Turkey

    • United States

    • Venezuela

    • Zaire

    International Drug Name Search

    Wednesday, 28 July 2010

    Clobex


    Clobex is a brand name of clobetasol topical, approved by the FDA in the following formulation(s):


    CLOBEX (clobetasol propionate - lotion; topical)



    • Manufacturer: GALDERMA LABS LP

      Approval date: July 24, 2003

      Strength(s): 0.05% [RLD][AB]

    CLOBEX (clobetasol propionate - shampoo; topical)



    • Manufacturer: GALDERMA LABS

      Approval date: February 5, 2004

      Strength(s): 0.05% [RLD][AB]

    CLOBEX (clobetasol propionate - spray; topical)



    • Manufacturer: GALDERMA LABS LP

      Approval date: October 27, 2005

      Strength(s): 0.05% [RLD][AT]

    Has a generic version of Clobex been approved?


    A generic version of Clobex has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Clobex and have been approved by the FDA:


    clobetasol propionate lotion; topical



    • Manufacturer: ACTAVIS MID ATLANTIC

      Approval date: December 4, 2008

      Strength(s): 0.05% [AB]

    clobetasol propionate shampoo; topical



    • Manufacturer: ACTAVIS MID ATLANTIC

      Approval date: June 7, 2011

      Strength(s): 0.05% [AB]

    clobetasol propionate spray; topical



    • Manufacturer: PADDOCK LLC

      Approval date: June 16, 2011

      Strength(s): 0.05% [AT]

    Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Clobex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

    See also: About generic drugs.




    Related Patents


    Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




    • Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
      Patent 5,972,920
      Issued: October 26, 1999
      Inventor(s): Seidel; William E.
      Assignee(s): Dermalogix Partners, Inc.
      One or more formulations for treating psoriasis and other skin disorders characterized by redness, itching, flaking, scaling, and plaque-type growth. The formulation includes a carrier component, one or more active ingredient components, and a surfactant component. The carrier preferably includes an alcohol in substantially equal volume with isopropyl myristate. The active ingredient component preferably includes a superpotent or high-potency corticosteroid such as clobetasol propionate, an anti-flaking ingredient such as zinc pyrithione, or a combination of the two. It may also include an anti-fungal compound. The surfactant component preferably includes an alkyl sulfate such as sodium lauryl sulfate. The formulations made by applied topically either in spray form or as a direct-contact liquid.
      Patent expiration dates:

      • February 12, 2018
        ✓ 
        Drug product




    • Composition and method for treatment of psoriasis
      Patent 5,990,100
      Issued: November 23, 1999
      Inventor(s): Rosenberg; E. William & Glenn; Thomas M. & Skinner, Jr.; Robert B. & Noah; Patricia W.
      Assignee(s): Panda Pharmaceuticals, L.L.C.
      The University of Tennessee Research Corporation
      Pharmaceutical compositions and methods for use in the treatment of psoriasis, having isopropyl myristate as a first active ingredient and a different anti-psoriatic agent as a second active ingredient; preferably they are combined in the same pharmaceutical composition.
      Patent expiration dates:

      • March 24, 2018
        ✓ 
        Patent use: TWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS.
        ✓ 
        Drug product




    • Topically applicable O/W emulsions having high glycol content and at least one biologically active agent
      Patent 6,106,848
      Issued: August 22, 2000
      Inventor(s): Preuilh; Isabelle & Willcox; Nathalie
      Assignee(s): Centre International de Recherches Dermatologiques
      Stable, topically applicable oil-in-water bioaffecting emulsions having intermediate viscosity, characteristically ranging from 3 to 10 Pa.multidot.s, comprise (a) from 30% to 50% by weight of at least one pro-penetrating glycol, (b) at least one emulsifying agent, advantageously an anionic amphiphilic polymer, and (c) at least one biologically active agent, for example an active agent that modulates skin differentiation and/or proliferation and/or pigmentation, an anti-inflammatory, an antibacterial, an antifungal, etc.
      Patent expiration dates:

      • September 22, 2017




    • Foaming composition for washing and treating hair and/or scalp based on an active principle
      Patent 7,316,810
      Issued: January 8, 2008
      Inventor(s): Preuilh; Isabelle & Guise; Anne-Emmanuelle & Willcox; Nathalie
      Assignee(s): Galderma S.A.
      The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterized in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
      Patent expiration dates:

      • June 17, 2019
        ✓ 
        Drug product




    • Foaming compositions for hair care
      Patent 7,700,081
      Issued: April 20, 2010
      Inventor(s): Preuilh; Isabelle & Guise; Anne-Emmanuelle & Willcox; Nathalie
      Assignee(s): Galderma S.A.
      The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterised in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
      Patent expiration dates:

      • January 3, 2022
        ✓ 
        Patent use: TOPICAL TREATMENT OF SCALP PSORIASIS




    • Foaming composition for washing and treating hair and/or scalp based on an active principle
      Patent 8,066,975
      Issued: November 29, 2011
      Inventor(s): Preuilh; Isabelle & Guise; Anne-Emmanuelle & Willcox; Nathalie
      Assignee(s): Galderma S.A.
      The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterized in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
      Patent expiration dates:

      • June 17, 2019
        ✓ 
        Drug product




    • Foaming compositions for hair care
      Patent 8,066,976
      Issued: November 29, 2011
      Inventor(s): Preuilh; Isabelle & Guise; Anne-Emmanuelle & Willcox; Nathalie
      Assignee(s): Galderma S.A.
      The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterised in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
      Patent expiration dates:

      • June 17, 2019
        ✓ 
        Drug product



    See also...

    • Clobex Lotion Consumer Information (Wolters Kluwer)
    • Clobex Shampoo Consumer Information (Wolters Kluwer)
    • Clobex Spray Consumer Information (Wolters Kluwer)
    • Clobex Consumer Information (Cerner Multum)
    • Clobex Advanced Consumer Information (Micromedex)
    • Clobetasol Cream Consumer Information (Wolters Kluwer)
    • Clobetasol Emollient Foam Consumer Information (Wolters Kluwer)
    • Clobetasol Foam Consumer Information (Wolters Kluwer)
    • Clobetasol Gel Consumer Information (Wolters Kluwer)
    • Clobetasol Lotion Consumer Information (Wolters Kluwer)
    • Clobetasol Shampoo Consumer Information (Wolters Kluwer)
    • Clobetasol Solution Consumer Information (Wolters Kluwer)
    • Clobetasol Spray Consumer Information (Wolters Kluwer)
    • Clobetasol topical Consumer Information (Cerner Multum)
    • Clobetasol Propionate Advanced Consumer Information (Micromedex)
    • Med Clobetasol Scalp Application Advanced Consumer Information (Micromedex)
    • Ratio-Clobetasol Advanced Consumer Information (Micromedex)
    • Clobetasol Topical application Advanced Consumer Information (Micromedex)
    • Clobetasol Propionate AHFS DI Monographs (ASHP)